Access
To read this story in full you will need to login or make a payment (see right).
Article
Nature Medicine 7, 1225 - 1231 (2001)
doi:10.1038/nm1101-1225
Protection of rhesus macaques against disease progression from pathogenic SHIV-89.6PD by vaccination with phage-displayed HIV-1 epitopes
Xueni Chen1, Giuseppe Scala1,2,3, Ileana Quinto1,2,3, Weimin Liu1, Tae-Wook Chun1, J. Shawn Justement1, Oren J. Cohen1, Tom C. vanCott4, Marcin Iwanicki4, Mark G. Lewis5, Jack Greenhouse5, Todd Barry6, David Venzon7 & Anthony S. Fauci1
Abstract
The antigenic polymorphism of HIV-1 is a major obstacle in developing an effective vaccine. Accordingly, we screened random peptide libraries (RPLs) displayed on phage with antibodies from HIV-infected individuals and identified an array of HIV-specific epitopes that behave as antigenic mimics of conformational epitopes of gp120 and gp41 proteins. We report that the selected epitopes are shared by a collection of HIV-1 isolates of clades A–F. The phage-borne epitopes are immunogenic in rhesus macaques, where they elicit envelope-specific antibody responses. Upon intravenous challenge with 60 MID50 of pathogenic SHIV-89.6PD, all monkeys became infected; however, in contrast to the naive and mock-immunized monkeys, four of five mimotope-immunized monkeys experienced lower levels of peak viremia, followed by viral set points of undetectable or transient levels of viremia and a mild decline of CD4+ T cells, and were protected from progression to AIDS-like illness. These results provide a new approach to the design of broadly protective HIV-1 vaccines.
To read this story in full you will need to login or make a payment (see right).
|
MORE ARTICLES LIKE THIS These links to content published by NPG are automatically generated REVIEWS NEWS AND VIEWS RESEARCH |
